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ABSTRACT 
 
Broken bone by road accident has become 24 million cases per year. Bone is 
one of the most transplanted tissue after blood, more than 2,2 million bone graft has 
been done in the world wide. Thus, in this study, carried out biocompatibility of 
scaffold composite from hydroxyapatite-chitosan-chondroin sulfate by inflammation 
level and osteoblast count in javanese rabbit’s (Lepus nigricollis). 
This research is a true-experiment with post test only control design. The 
instrument used was hematology analizer and light microscope. Where to see 
difference groups was performed using hypotesis. There are three difference groups : 
negative control group, positive control group and implanted group. Each group has 
three observation time : 7th, 21st, dan 56th day. 
Blood laboratory result showed that implanted group has the highest 
inflammation in 7th day (WBC 7,02 x 1012 cell/L) but it has the lowest inflamation 
(WBC 3,64 x 1012cell/L) in 56th day. Based on histopatology result, implanted group 
has the highest count of osteoblast (52,33 ± 10,73, 70,00 ± 26,99 and 61,67 ± 10,58) 
and woven bone, lamellar bone, haverssystem dan bone repair in 7th, 21st, dan 56th 
day. 
Further development of scaffold composite from hydroxyapatite-chitosan-
chondroin sulfate for bone graft can be done with other large animal experiments. So 
scaffold composite from hydroxyapatite-chitosan-chondroin sulfate can become one 
of the ideal bone graft for broken bone. 
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